aclacinomycin has been researched along with id-6105 in 2 studies
Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (id-6105) | Trials (id-6105) | Recent Studies (post-2010) (id-6105) |
---|---|---|---|---|---|
168 | 8 | 21 | 7 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, YS; Kim, HS; Kim, YH; Lee, JJ; Yoo, OJ | 1 |
Kim, HS; Kim, YH; Lee, JJ; Yoo, OJ | 1 |
2 other study(ies) available for aclacinomycin and id-6105
Article | Year |
---|---|
New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
Topics: Aclarubicin; Anthracyclines; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Streptomyces | 1996 |
Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
Topics: Aclarubicin; Adjuvants, Immunologic; Antibiotics, Antineoplastic; Cell Division; Culture Media; Humans; Leukemia; Magnetic Resonance Spectroscopy; Melanoma; Streptomyces; Tumor Cells, Cultured | 1996 |